PRISTIQ

This brand name is authorized in Australia, Brazil, Canada, Ecuador, Spain, Hong Kong, Mexico, Singapore, United States

Active ingredients

The drug PRISTIQ contains one active pharmaceutical ingredient (API):

1 Desvenlafaxine UNII ZB22ENF0XR - DESVENLAFAXINE SUCCINATE

Desvenlafaxine is a potent and selective serotonin and norepinephrine reuptake inhibitor (SNRI), indicated for the treatment of major depressive disorder [MDD]. The clinical efficacy of desvenlafaxine is thought to be related to the potentiation of these neurotransmitters in the central nervous system.

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
PRISTIQ Extended-release tablet	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N06AX23	Desvenlafaxine	N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AX Other antidepressants
Discover more medicines within N06AX23

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 9366Y, 9367B
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 522710305111213, 522710306116219, 522710307112217, 522710308119215, 522710310113210
Country: CA	Health Products and Food Branch	Identifier(s): 02321092, 02321106
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): H7501013, H7511013
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 75560, 75561
Country: HK	Department of Health Drug Office	Identifier(s): 59472, 59473, 65147
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 016M2009
Country: SG	Health Sciences Authority	Identifier(s): 13858P, 13859P
Country: US	FDA, National Drug Code	Identifier(s): 0008-1210, 0008-1211, 0008-1222, 43063-262